Global Sepsis Detection Kit Supply, Demand and Key Producers, 2026-2032
The global Sepsis Detection Kit market size is expected to reach $ 1500 million by 2032, rising at a market growth of 8.4% CAGR during the forecast period (2026-2032).
Sepsis Detection Kits are reagents, cartridges, reaction boxes, and disposable testing consumables that use human whole blood, serum, plasma, positive blood culture samples, or other clinical samples as the detection targets. They employ immunoassay, chemiluminescence, fluorescence immunoassay, polymerase chain reaction, real-time reverse transcription PCR, multiplex molecular detection, microfluidics, magnetic resonance imaging, mass spectrometry sample pretreatment, leukocyte biophysical analysis, or other in vitro diagnostic techniques to qualitatively or quantitatively analyze host response markers, gene expression characteristics, immune cell status, bacterial or fungal nucleic acids, and drug resistance genes related to sepsis.
Key Findings: Global sepsis cases estimated at 48.9 million annually; Blood culture remains core for pathogen identification; Procalcitonin supports routine risk assessment; Mature molecular panel analyzes 43 targets per hour; Host response detection differentiates infectious inflammation. Industry Trends: The sepsis diagnostic kit market is evolving from single-marker detection and traditional culture-dependent diagnostic processes to a multi-layered diagnostic pathway integrating host response assessment, rapid pathogen identification, and drug resistance information. Procalcitonin remains a mature tool for bacterial infection and sepsis risk assessment, while novel gene expression detection helps differentiate between infectious and non-infectious systemic inflammation by analyzing patient immune responses. Molecular panel analysis is simultaneously expanding target coverage and shortening reporting time; cartridge systems can identify multiple bacteria, yeasts, and drug resistance genes within approximately one hour after a positive blood culture. Direct whole blood testing technology is another important development direction, reducing reliance on positive blood cultures for specific pathogens. Product upgrades also include reduced sample size, automated pretreatment, sealed consumables, simplified result interpretation, and deep integration with hospital antimicrobial management processes. In the long term, the market trend is not towards a single, universal test, but rather towards a tiered diagnostic system comprised of rapid screening, risk stratification, etiological confirmation, and treatment guidance.
The fundamental driver of demand for sepsis diagnostic kits stems from the high disease burden and rapidly progressing clinical characteristics. Global health agencies estimate that tens of millions of people develop sepsis each year, and if identification and treatment are delayed, patients can rapidly progress to septic shock, multiple organ failure, and even death. Hospitals are therefore continuously strengthening standardized sepsis management programs, emergency assessment procedures, and laboratory testing pathways, promoting the standardized application of blood cultures, lactate, and other auxiliary tests. Biomarker kits can support early assessment of bacterial infection and disease progression risk, while molecular assay panels can shorten the time from a positive sample to obtaining actionable pathogen information. Increased requirements for antimicrobial management are also a significant driver; bacterial infection identification, pathogen recognition, and resistance biomarker detection help to initiate, adjust, or discontinue antimicrobial therapy more promptly within validated clinical pathways.
Limitations
The market remains limited by the biological heterogeneity of sepsis and the lack of a single, independent diagnostic test. Biomarker levels can be influenced by infection severity, sampling time, underlying diseases, surgery, trauma, and other inflammatory states, and therefore must be interpreted in conjunction with clinical assessment and supplemental laboratory results. Molecular pathogen panels have well-defined target ranges and cannot identify pathogens or resistance mechanisms outside the testing menu; some products also rely on positive blood cultures, limiting the extent to which overall diagnostic time can be reduced. Direct whole blood testing and host response testing can reduce some procedural delays, but typically require specialized equipment, trained personnel, quality control systems, and clinically validated result interpretation rules. Equipment investment, per-test consumable costs, regulatory requirements, and insufficient laboratory infrastructure also limit their adoption in resource-constrained healthcare systems.
Market Opportunities: The most attractive opportunities lie in technologies that can shorten the time lag between clinically suspected sepsis and access to actionable laboratory information. Direct whole blood pathogen testing can overcome some limitations of culture-dependent testing, while host response gene expression testing can help differentiate sepsis from non-infectious systemic inflammation when the pathogen is not yet identified. There is further room for development in broader multiplex pathogen panels, resistance gene coverage, pediatric and neonatal applications, in-hospital decentralized testing, and software-aided interpretation of test results in conjunction with clinical variables. The market, with its inadequate blood culture infrastructure, has a long-standing need for affordable, simplified, and reliable near-patient testing products. Suppliers capable of demonstrating clinical efficacy, rapid reporting, low manual intervention, and compatibility with existing laboratory platforms have a greater opportunity to extend beyond simple reagent sales to comprehensive hospital sepsis management processes.
Industry Risks and Challenges The core challenge in the industry lies in translating stable analytical performance into clinical benefits across different patient populations and healthcare scenarios. Sepsis presentation varies significantly depending on infection site, pathogen type, age, immune status, and disease stage, making the establishment of uniform thresholds and universal detection algorithms more complex. Manufacturers need to validate product performance in representative patient populations, control contamination and cross-reactivity, and clarify the impact of negative, positive, or indeterminate results on subsequent testing. Molecular assays also need to address issues such as off-panel pathogens, inactive nucleic acids, and the inability of specific resistance markers to cover all resistance mechanisms. Hospitals face the challenge of integrating rapid results into emergency, intensive care, and antibiotic management processes. Regulatory approvals, health economics evidence, payment mechanisms, equipment standardization, and post-market quality monitoring will continue to impact product commercialization.
Supply Chain Analysis: The upstream of the sepsis testing kit supply chain mainly includes antibodies, antigens, enzymes, primers, probes, reference materials, calibrators, quality control materials, magnetic particles, membrane materials, microfluidic components, and medical-grade plastics. Biomarker immunoassays highly rely on antibody specificity, calibration consistency, and stable detection chemistry systems; molecular products require reliable nucleic acid extraction, amplification reagents, target design, and contamination control. Host reaction assays further increase requirements for RNA stability, gene expression normalization, and algorithm development. Equipment cartridges and sealed reagent kits also involve precision injection molding, lyophilization processes, fluid control components, and validated packaging systems. Because sepsis testing is conducted in highly time-sensitive clinical settings, supplier certification, batch consistency, cold chain management, and raw material traceability directly affect product reliability and regulatory compliance.
The midstream value creation segment encompasses biomarker screening, assay design, clinical validation, reagent formulation, cartridge manufacturing, software development, regulatory registration, and integration with diagnostic equipment. Higher value-added capabilities in the industry typically lie in proprietary biomarkers or target combinations, clinically validated algorithms, automated sample input and output processes, and established analytical platforms. Downstream demand primarily comes from hospital laboratories, emergency departments, intensive care units, infectious disease departments, and central laboratories. Distributors and local service providers handle equipment deployment, reagent supply, training, and maintenance. Profitability depends not only on reagent production costs but also on clinical evidence, regulatory status, breadth of assays, repurchase of consumables, equipment utilization, and the product's integration into existing hospital diagnostic workflows.
Segmented Market Analysis: Biomarker-based reagent kits represent a highly commercialized segment, deployable on widely installed immunoassay and clinical biochemistry platforms. Procalcitonin plays a crucial role in bacterial infection assessment, sepsis progression risk assessment, and antimicrobial management pathways. Its main advantages lie in providing standardized quantitative results, relatively short testing times, and compatibility with routine serum or plasma testing procedures. However, biomarkers primarily reflect host responses and cannot directly identify pathogenic agents; therefore, continuous monitoring and comprehensive clinical interpretation remain crucial. Other inflammation or organ function-related indicators can supplement the diagnostic pathway, but their performance and role vary across patient populations and clinical procedures.
Molecular pathogen panels represent a major technological upgrade direction, enabling significantly faster identification of multiple bloodstream pathogens and specific drug resistance genes than traditional identification methods after a positive blood culture. Direct whole blood testing can further shorten the diagnostic pathway by targeting specific targets, but its detection range is still limited by the included species and biomarkers. Host response gene expression kits represent a smaller, emerging segment; their differentiating value lies in estimating the likelihood of sepsis by measuring the patient's immune response, rather than simply identifying microbial targets. Commercial opportunities across different technology segments are gradually shifting towards combined detection strategies: biomarkers support early risk assessment, host response testing supports differential diagnosis, and pathogen panels provide etiological and drug resistance information.
Downstream Market Opportunities: Hospital emergency and critical care pathways constitute core downstream opportunities due to the highly time-sensitive nature of diagnostic decisions and the frequent need for repeated testing. Emergency departments require rapid tools for triaging suspected infected patients, while intensive care units need risk stratification, continuous monitoring, and decision support for antimicrobial therapy. Clinical microbiology laboratories are increasingly focusing on multiplex panels that reduce manual identification steps and provide pathogen and resistance information in a standardized format. New application opportunities are also emerging in pediatric and neonatal care, postoperative monitoring, immunocompromised patients, and regional hospitals seeking simplified sample input and output systems. Commercially valuable products need to be compatible with existing sample workflows, provide interpretable results within the clinical decision window, and effectively complement blood cultures, clinical biochemistry, and microbiological testing, rather than simply repeating existing processes.
Regional Analysis: North America is a region with a relatively mature commercialization of sepsis diagnostic kits, primarily due to well-developed hospital laboratory infrastructure, relatively standardized sepsis management programs, and regulatory pathways covering biomarkers, molecular pathogens, and host response testing. Approved procalcitonin assays, blood culture identification panels, direct whole blood molecular assays, and host response products collectively form a diverse technological landscape. Market adoption is increasingly driven by clinical utility, integration of antimicrobial administration, payment terms, and the ability to improve laboratory and patient management efficiency, rather than simply the novelty of analytical technologies. Europe, also a mature market with a strong foundation in immunoassays and molecular diagnostic platforms, faces challenges in commercialization due to differences in procurement, payment, and regulatory implementation across countries.
The Asia-Pacific, Latin America, Middle East, and Africa regions have significant unmet diagnostic needs, but these markets exhibit marked differences in laboratory capabilities, testing accessibility, and affordability. Higher patient numbers and severe infection burdens create a demand for rapid diagnostics, while insufficient microbiology laboratory infrastructure in some regions increases the focus on automated, stable, and low-complexity systems. Products with shorter turnaround times, stable consumable supplies, and the ability to fit regional hospital budgets have greater expansion potential, but business models must cover equipment deployment, service networks, personnel training, and local regulatory registration. Therefore, this report argues that regional growth potential depends not only on clinical demand but also on laboratory readiness and the ability of suppliers to establish sustainable distribution and technical support systems.
Competitive Landscape: The sepsis testing kit market exhibits a stratified competitive structure, rather than a single, homogeneous product market. Large in vitro diagnostic (IVD) companies compete primarily by leveraging their extensive equipment infrastructure, automated immunoassay assays, regulatory experience, and established reagent supply relationships with hospital laboratories. Molecular diagnostic specialists differentiate themselves through multi-target coverage, rapid cartridge workflows, pathogen and resistance gene assays, and simplified sample input and output procedures. Emerging host response and direct whole blood assay companies focus on addressing diagnostic needs not yet fully met by traditional biomarkers and culture-dependent panel assays. Competitive advantage depends on clinical validation, time-to-result, analytical reliability, breadth of assays, equipment accessibility, regulatory approval, evidence of antimicrobial administration, and integration with hospital information and treatment workflows. Price competition remains important, but hospitals must also consider equipment utilization, staff time, repeat testing, service support, and the impact of delayed or ambiguous results.
This report is a detailed and comprehensive analysis of the world market for Sepsis Detection Kit and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Sepsis Detection Kit that contribute to its increasing demand across many markets.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Sepsis Detection Kit market
2. What is the demand of the global Sepsis Detection Kit market?
3. What is the year over year growth of the global Sepsis Detection Kit market?
4. What is the production and production value of the global Sepsis Detection Kit market?
5. Who are the key producers in the global Sepsis Detection Kit market?
6. What are the growth factors driving the market demand?
Sepsis Detection Kits are reagents, cartridges, reaction boxes, and disposable testing consumables that use human whole blood, serum, plasma, positive blood culture samples, or other clinical samples as the detection targets. They employ immunoassay, chemiluminescence, fluorescence immunoassay, polymerase chain reaction, real-time reverse transcription PCR, multiplex molecular detection, microfluidics, magnetic resonance imaging, mass spectrometry sample pretreatment, leukocyte biophysical analysis, or other in vitro diagnostic techniques to qualitatively or quantitatively analyze host response markers, gene expression characteristics, immune cell status, bacterial or fungal nucleic acids, and drug resistance genes related to sepsis.
Key Findings: Global sepsis cases estimated at 48.9 million annually; Blood culture remains core for pathogen identification; Procalcitonin supports routine risk assessment; Mature molecular panel analyzes 43 targets per hour; Host response detection differentiates infectious inflammation. Industry Trends: The sepsis diagnostic kit market is evolving from single-marker detection and traditional culture-dependent diagnostic processes to a multi-layered diagnostic pathway integrating host response assessment, rapid pathogen identification, and drug resistance information. Procalcitonin remains a mature tool for bacterial infection and sepsis risk assessment, while novel gene expression detection helps differentiate between infectious and non-infectious systemic inflammation by analyzing patient immune responses. Molecular panel analysis is simultaneously expanding target coverage and shortening reporting time; cartridge systems can identify multiple bacteria, yeasts, and drug resistance genes within approximately one hour after a positive blood culture. Direct whole blood testing technology is another important development direction, reducing reliance on positive blood cultures for specific pathogens. Product upgrades also include reduced sample size, automated pretreatment, sealed consumables, simplified result interpretation, and deep integration with hospital antimicrobial management processes. In the long term, the market trend is not towards a single, universal test, but rather towards a tiered diagnostic system comprised of rapid screening, risk stratification, etiological confirmation, and treatment guidance.
Market Dynamics
Driven FactorsThe fundamental driver of demand for sepsis diagnostic kits stems from the high disease burden and rapidly progressing clinical characteristics. Global health agencies estimate that tens of millions of people develop sepsis each year, and if identification and treatment are delayed, patients can rapidly progress to septic shock, multiple organ failure, and even death. Hospitals are therefore continuously strengthening standardized sepsis management programs, emergency assessment procedures, and laboratory testing pathways, promoting the standardized application of blood cultures, lactate, and other auxiliary tests. Biomarker kits can support early assessment of bacterial infection and disease progression risk, while molecular assay panels can shorten the time from a positive sample to obtaining actionable pathogen information. Increased requirements for antimicrobial management are also a significant driver; bacterial infection identification, pathogen recognition, and resistance biomarker detection help to initiate, adjust, or discontinue antimicrobial therapy more promptly within validated clinical pathways.
Limitations
The market remains limited by the biological heterogeneity of sepsis and the lack of a single, independent diagnostic test. Biomarker levels can be influenced by infection severity, sampling time, underlying diseases, surgery, trauma, and other inflammatory states, and therefore must be interpreted in conjunction with clinical assessment and supplemental laboratory results. Molecular pathogen panels have well-defined target ranges and cannot identify pathogens or resistance mechanisms outside the testing menu; some products also rely on positive blood cultures, limiting the extent to which overall diagnostic time can be reduced. Direct whole blood testing and host response testing can reduce some procedural delays, but typically require specialized equipment, trained personnel, quality control systems, and clinically validated result interpretation rules. Equipment investment, per-test consumable costs, regulatory requirements, and insufficient laboratory infrastructure also limit their adoption in resource-constrained healthcare systems.
Market Opportunities: The most attractive opportunities lie in technologies that can shorten the time lag between clinically suspected sepsis and access to actionable laboratory information. Direct whole blood pathogen testing can overcome some limitations of culture-dependent testing, while host response gene expression testing can help differentiate sepsis from non-infectious systemic inflammation when the pathogen is not yet identified. There is further room for development in broader multiplex pathogen panels, resistance gene coverage, pediatric and neonatal applications, in-hospital decentralized testing, and software-aided interpretation of test results in conjunction with clinical variables. The market, with its inadequate blood culture infrastructure, has a long-standing need for affordable, simplified, and reliable near-patient testing products. Suppliers capable of demonstrating clinical efficacy, rapid reporting, low manual intervention, and compatibility with existing laboratory platforms have a greater opportunity to extend beyond simple reagent sales to comprehensive hospital sepsis management processes.
Industry Risks and Challenges The core challenge in the industry lies in translating stable analytical performance into clinical benefits across different patient populations and healthcare scenarios. Sepsis presentation varies significantly depending on infection site, pathogen type, age, immune status, and disease stage, making the establishment of uniform thresholds and universal detection algorithms more complex. Manufacturers need to validate product performance in representative patient populations, control contamination and cross-reactivity, and clarify the impact of negative, positive, or indeterminate results on subsequent testing. Molecular assays also need to address issues such as off-panel pathogens, inactive nucleic acids, and the inability of specific resistance markers to cover all resistance mechanisms. Hospitals face the challenge of integrating rapid results into emergency, intensive care, and antibiotic management processes. Regulatory approvals, health economics evidence, payment mechanisms, equipment standardization, and post-market quality monitoring will continue to impact product commercialization.
Supply Chain Analysis: The upstream of the sepsis testing kit supply chain mainly includes antibodies, antigens, enzymes, primers, probes, reference materials, calibrators, quality control materials, magnetic particles, membrane materials, microfluidic components, and medical-grade plastics. Biomarker immunoassays highly rely on antibody specificity, calibration consistency, and stable detection chemistry systems; molecular products require reliable nucleic acid extraction, amplification reagents, target design, and contamination control. Host reaction assays further increase requirements for RNA stability, gene expression normalization, and algorithm development. Equipment cartridges and sealed reagent kits also involve precision injection molding, lyophilization processes, fluid control components, and validated packaging systems. Because sepsis testing is conducted in highly time-sensitive clinical settings, supplier certification, batch consistency, cold chain management, and raw material traceability directly affect product reliability and regulatory compliance.
The midstream value creation segment encompasses biomarker screening, assay design, clinical validation, reagent formulation, cartridge manufacturing, software development, regulatory registration, and integration with diagnostic equipment. Higher value-added capabilities in the industry typically lie in proprietary biomarkers or target combinations, clinically validated algorithms, automated sample input and output processes, and established analytical platforms. Downstream demand primarily comes from hospital laboratories, emergency departments, intensive care units, infectious disease departments, and central laboratories. Distributors and local service providers handle equipment deployment, reagent supply, training, and maintenance. Profitability depends not only on reagent production costs but also on clinical evidence, regulatory status, breadth of assays, repurchase of consumables, equipment utilization, and the product's integration into existing hospital diagnostic workflows.
Segmented Market Analysis: Biomarker-based reagent kits represent a highly commercialized segment, deployable on widely installed immunoassay and clinical biochemistry platforms. Procalcitonin plays a crucial role in bacterial infection assessment, sepsis progression risk assessment, and antimicrobial management pathways. Its main advantages lie in providing standardized quantitative results, relatively short testing times, and compatibility with routine serum or plasma testing procedures. However, biomarkers primarily reflect host responses and cannot directly identify pathogenic agents; therefore, continuous monitoring and comprehensive clinical interpretation remain crucial. Other inflammation or organ function-related indicators can supplement the diagnostic pathway, but their performance and role vary across patient populations and clinical procedures.
Molecular pathogen panels represent a major technological upgrade direction, enabling significantly faster identification of multiple bloodstream pathogens and specific drug resistance genes than traditional identification methods after a positive blood culture. Direct whole blood testing can further shorten the diagnostic pathway by targeting specific targets, but its detection range is still limited by the included species and biomarkers. Host response gene expression kits represent a smaller, emerging segment; their differentiating value lies in estimating the likelihood of sepsis by measuring the patient's immune response, rather than simply identifying microbial targets. Commercial opportunities across different technology segments are gradually shifting towards combined detection strategies: biomarkers support early risk assessment, host response testing supports differential diagnosis, and pathogen panels provide etiological and drug resistance information.
Downstream Market Opportunities: Hospital emergency and critical care pathways constitute core downstream opportunities due to the highly time-sensitive nature of diagnostic decisions and the frequent need for repeated testing. Emergency departments require rapid tools for triaging suspected infected patients, while intensive care units need risk stratification, continuous monitoring, and decision support for antimicrobial therapy. Clinical microbiology laboratories are increasingly focusing on multiplex panels that reduce manual identification steps and provide pathogen and resistance information in a standardized format. New application opportunities are also emerging in pediatric and neonatal care, postoperative monitoring, immunocompromised patients, and regional hospitals seeking simplified sample input and output systems. Commercially valuable products need to be compatible with existing sample workflows, provide interpretable results within the clinical decision window, and effectively complement blood cultures, clinical biochemistry, and microbiological testing, rather than simply repeating existing processes.
Regional Analysis: North America is a region with a relatively mature commercialization of sepsis diagnostic kits, primarily due to well-developed hospital laboratory infrastructure, relatively standardized sepsis management programs, and regulatory pathways covering biomarkers, molecular pathogens, and host response testing. Approved procalcitonin assays, blood culture identification panels, direct whole blood molecular assays, and host response products collectively form a diverse technological landscape. Market adoption is increasingly driven by clinical utility, integration of antimicrobial administration, payment terms, and the ability to improve laboratory and patient management efficiency, rather than simply the novelty of analytical technologies. Europe, also a mature market with a strong foundation in immunoassays and molecular diagnostic platforms, faces challenges in commercialization due to differences in procurement, payment, and regulatory implementation across countries.
The Asia-Pacific, Latin America, Middle East, and Africa regions have significant unmet diagnostic needs, but these markets exhibit marked differences in laboratory capabilities, testing accessibility, and affordability. Higher patient numbers and severe infection burdens create a demand for rapid diagnostics, while insufficient microbiology laboratory infrastructure in some regions increases the focus on automated, stable, and low-complexity systems. Products with shorter turnaround times, stable consumable supplies, and the ability to fit regional hospital budgets have greater expansion potential, but business models must cover equipment deployment, service networks, personnel training, and local regulatory registration. Therefore, this report argues that regional growth potential depends not only on clinical demand but also on laboratory readiness and the ability of suppliers to establish sustainable distribution and technical support systems.
Competitive Landscape: The sepsis testing kit market exhibits a stratified competitive structure, rather than a single, homogeneous product market. Large in vitro diagnostic (IVD) companies compete primarily by leveraging their extensive equipment infrastructure, automated immunoassay assays, regulatory experience, and established reagent supply relationships with hospital laboratories. Molecular diagnostic specialists differentiate themselves through multi-target coverage, rapid cartridge workflows, pathogen and resistance gene assays, and simplified sample input and output procedures. Emerging host response and direct whole blood assay companies focus on addressing diagnostic needs not yet fully met by traditional biomarkers and culture-dependent panel assays. Competitive advantage depends on clinical validation, time-to-result, analytical reliability, breadth of assays, equipment accessibility, regulatory approval, evidence of antimicrobial administration, and integration with hospital information and treatment workflows. Price competition remains important, but hospitals must also consider equipment utilization, staff time, repeat testing, service support, and the impact of delayed or ambiguous results.
Report Scope
This report studies the global Sepsis Detection Kit production, demand, key manufacturers, and key regions.This report is a detailed and comprehensive analysis of the world market for Sepsis Detection Kit and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Sepsis Detection Kit that contribute to its increasing demand across many markets.
Highlights and key features of the study
- Global Sepsis Detection Kit total production and demand, 2021-2032, (K Units)
- Global Sepsis Detection Kit total production value, 2021-2032, (USD Million)
- Global Sepsis Detection Kit production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Units), (based on production site)
- Global Sepsis Detection Kit consumption by region & country, CAGR, 2021-2032 & (K Units)
- U.S. VS China: Sepsis Detection Kit domestic production, consumption, key domestic manufacturers and share
- Global Sepsis Detection Kit production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Units)
- Global Sepsis Detection Kit production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
- Global Sepsis Detection Kit production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Sepsis Detection Kit market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.Global Sepsis Detection Kit Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
Global Sepsis Detection Kit Market, Segmentation by Type:
- Immunochromatography
- Molecular Biology
Global Sepsis Detection Kit Market, Segmentation by Detection Target:
- Single Biomarker
- Multi-indicator Combined Detection
Global Sepsis Detection Kit Market, Segmentation by Detection Time:
- ≤30 minutes
- 0.5~4 hours
- ≥4 hours
Global Sepsis Detection Kit Market, Segmentation by Application:
- General Hospitals
- Medical Laboratory (ICL) Industry
- Maternal and Child Health Industry
- Others
Companies Profiled:
- BioM?rieux SA
- Roche Holding Ltd
- Thermo Fisher Scientific Inc.
- Abbott Laboratories
- Siemens Healthineers AG
- DiaSorin S.p.A.
- QuidelOrtho Corporation
- PHC Holdings Corporation
- Sysmex Corporation
- Bruker Corporation
- Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
- T2 Biosystems, Inc.
- Guangzhou Wondfo Biotech Co., Ltd.
- Getein Biotech, Inc.
- Boditech Med Inc.
- SD Biosensor, Inc.
- Cytovale, Inc.
- Immunexpress Pty Ltd
- Inflammatix, Inc.
- QIAGEN N.V.
Key Questions Answered:
1. How big is the global Sepsis Detection Kit market?2. What is the demand of the global Sepsis Detection Kit market?
3. What is the year over year growth of the global Sepsis Detection Kit market?
4. What is the production and production value of the global Sepsis Detection Kit market?
5. Who are the key producers in the global Sepsis Detection Kit market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Sepsis Detection Kit Introduction
1.2 World Sepsis Detection Kit Supply & Forecast
1.2.1 World Sepsis Detection Kit Production Value (2021 & 2025 & 2032)
1.2.2 World Sepsis Detection Kit Production (2021-2032)
1.2.3 World Sepsis Detection Kit Pricing Trends (2021-2032)
1.3 World Sepsis Detection Kit Production by Region (Based on Production Site)
1.3.1 World Sepsis Detection Kit Production Value by Region (2021-2032)
1.3.2 World Sepsis Detection Kit Production by Region (2021-2032)
1.3.3 World Sepsis Detection Kit Average Price by Region (2021-2032)
1.3.4 North America Sepsis Detection Kit Production (2021-2032)
1.3.5 Europe Sepsis Detection Kit Production (2021-2032)
1.3.6 China Sepsis Detection Kit Production (2021-2032)
1.3.7 Japan Sepsis Detection Kit Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Sepsis Detection Kit Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Sepsis Detection Kit Major Market Trends
2 DEMAND SUMMARY
2.1 World Sepsis Detection Kit Demand (2021-2032)
2.2 World Sepsis Detection Kit Consumption by Region
2.2.1 World Sepsis Detection Kit Consumption by Region (2021-2026)
2.2.2 World Sepsis Detection Kit Consumption Forecast by Region (2027-2032)
2.3 United States Sepsis Detection Kit Consumption (2021-2032)
2.4 China Sepsis Detection Kit Consumption (2021-2032)
2.5 Europe Sepsis Detection Kit Consumption (2021-2032)
2.6 Japan Sepsis Detection Kit Consumption (2021-2032)
2.7 South Korea Sepsis Detection Kit Consumption (2021-2032)
2.8 ASEAN Sepsis Detection Kit Consumption (2021-2032)
2.9 India Sepsis Detection Kit Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Sepsis Detection Kit Production Value by Manufacturer (2021-2026)
3.2 World Sepsis Detection Kit Production by Manufacturer (2021-2026)
3.3 World Sepsis Detection Kit Average Price by Manufacturer (2021-2026)
3.4 Sepsis Detection Kit Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Sepsis Detection Kit Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Sepsis Detection Kit in 2025
3.5.3 Global Concentration Ratios (CR8) for Sepsis Detection Kit in 2025
3.6 Sepsis Detection Kit Market: Overall Company Footprint Analysis
3.6.1 Sepsis Detection Kit Market: Region Footprint
3.6.2 Sepsis Detection Kit Market: Company Product Type Footprint
3.6.3 Sepsis Detection Kit Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Sepsis Detection Kit Production Value Comparison
4.1.1 United States VS China: Sepsis Detection Kit Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Sepsis Detection Kit Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Sepsis Detection Kit Production Comparison
4.2.1 United States VS China: Sepsis Detection Kit Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Sepsis Detection Kit Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Sepsis Detection Kit Consumption Comparison
4.3.1 United States VS China: Sepsis Detection Kit Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Sepsis Detection Kit Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Sepsis Detection Kit Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Sepsis Detection Kit Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Sepsis Detection Kit Production Value (2021-2026)
4.4.3 United States Based Manufacturers Sepsis Detection Kit Production (2021-2026)
4.5 China Based Sepsis Detection Kit Manufacturers and Market Share
4.5.1 China Based Sepsis Detection Kit Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Sepsis Detection Kit Production Value (2021-2026)
4.5.3 China Based Manufacturers Sepsis Detection Kit Production (2021-2026)
4.6 Rest of World Based Sepsis Detection Kit Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Sepsis Detection Kit Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Sepsis Detection Kit Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Sepsis Detection Kit Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Sepsis Detection Kit Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Immunochromatography
5.2.2 Molecular Biology
5.3 Market Segment by Type
5.3.1 World Sepsis Detection Kit Production by Type (2021-2032)
5.3.2 World Sepsis Detection Kit Production Value by Type (2021-2032)
5.3.3 World Sepsis Detection Kit Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY DETECTION TARGET
6.1 World Sepsis Detection Kit Market Size Overview by Detection Target: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Detection Target
6.2.1 Single Biomarker
6.2.2 Multi-indicator Combined Detection
6.3 Market Segment by Detection Target
6.3.1 World Sepsis Detection Kit Production by Detection Target (2021-2032)
6.3.2 World Sepsis Detection Kit Production Value by Detection Target (2021-2032)
6.3.3 World Sepsis Detection Kit Average Price by Detection Target (2021-2032)
7 MARKET ANALYSIS BY DETECTION TIME
7.1 World Sepsis Detection Kit Market Size Overview by Detection Time: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Detection Time
7.2.1 ≤30 minutes
7.2.2 0.5~4 hours
7.2.3 ≥4 hours
7.3 Market Segment by Detection Time
7.3.1 World Sepsis Detection Kit Production by Detection Time (2021-2032)
7.3.2 World Sepsis Detection Kit Production Value by Detection Time (2021-2032)
7.3.3 World Sepsis Detection Kit Average Price by Detection Time (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Sepsis Detection Kit Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 General Hospitals
8.2.2 Medical Laboratory (ICL) Industry
8.2.3 Maternal and Child Health Industry
8.2.4 Others
8.3 Market Segment by Application
8.3.1 World Sepsis Detection Kit Production by Application (2021-2032)
8.3.2 World Sepsis Detection Kit Production Value by Application (2021-2032)
8.3.3 World Sepsis Detection Kit Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 BioM?rieux SA
9.1.1 BioM?rieux SA Details
9.1.2 BioM?rieux SA Major Business
9.1.3 BioM?rieux SA Sepsis Detection Kit Product and Services
9.1.4 BioM?rieux SA Sepsis Detection Kit Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 BioM?rieux SA Recent Developments/Updates
9.1.6 BioM?rieux SA Competitive Strengths & Weaknesses
9.2 Roche Holding Ltd
9.2.1 Roche Holding Ltd Details
9.2.2 Roche Holding Ltd Major Business
9.2.3 Roche Holding Ltd Sepsis Detection Kit Product and Services
9.2.4 Roche Holding Ltd Sepsis Detection Kit Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 Roche Holding Ltd Recent Developments/Updates
9.2.6 Roche Holding Ltd Competitive Strengths & Weaknesses
9.3 Thermo Fisher Scientific Inc.
9.3.1 Thermo Fisher Scientific Inc. Details
9.3.2 Thermo Fisher Scientific Inc. Major Business
9.3.3 Thermo Fisher Scientific Inc. Sepsis Detection Kit Product and Services
9.3.4 Thermo Fisher Scientific Inc. Sepsis Detection Kit Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 Thermo Fisher Scientific Inc. Recent Developments/Updates
9.3.6 Thermo Fisher Scientific Inc. Competitive Strengths & Weaknesses
9.4 Abbott Laboratories
9.4.1 Abbott Laboratories Details
9.4.2 Abbott Laboratories Major Business
9.4.3 Abbott Laboratories Sepsis Detection Kit Product and Services
9.4.4 Abbott Laboratories Sepsis Detection Kit Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 Abbott Laboratories Recent Developments/Updates
9.4.6 Abbott Laboratories Competitive Strengths & Weaknesses
9.5 Siemens Healthineers AG
9.5.1 Siemens Healthineers AG Details
9.5.2 Siemens Healthineers AG Major Business
9.5.3 Siemens Healthineers AG Sepsis Detection Kit Product and Services
9.5.4 Siemens Healthineers AG Sepsis Detection Kit Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.5.5 Siemens Healthineers AG Recent Developments/Updates
9.5.6 Siemens Healthineers AG Competitive Strengths & Weaknesses
9.6 DiaSorin S.p.A.
9.6.1 DiaSorin S.p.A. Details
9.6.2 DiaSorin S.p.A. Major Business
9.6.3 DiaSorin S.p.A. Sepsis Detection Kit Product and Services
9.6.4 DiaSorin S.p.A. Sepsis Detection Kit Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.6.5 DiaSorin S.p.A. Recent Developments/Updates
9.6.6 DiaSorin S.p.A. Competitive Strengths & Weaknesses
9.7 QuidelOrtho Corporation
9.7.1 QuidelOrtho Corporation Details
9.7.2 QuidelOrtho Corporation Major Business
9.7.3 QuidelOrtho Corporation Sepsis Detection Kit Product and Services
9.7.4 QuidelOrtho Corporation Sepsis Detection Kit Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.7.5 QuidelOrtho Corporation Recent Developments/Updates
9.7.6 QuidelOrtho Corporation Competitive Strengths & Weaknesses
9.8 PHC Holdings Corporation
9.8.1 PHC Holdings Corporation Details
9.8.2 PHC Holdings Corporation Major Business
9.8.3 PHC Holdings Corporation Sepsis Detection Kit Product and Services
9.8.4 PHC Holdings Corporation Sepsis Detection Kit Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.8.5 PHC Holdings Corporation Recent Developments/Updates
9.8.6 PHC Holdings Corporation Competitive Strengths & Weaknesses
9.9 Sysmex Corporation
9.9.1 Sysmex Corporation Details
9.9.2 Sysmex Corporation Major Business
9.9.3 Sysmex Corporation Sepsis Detection Kit Product and Services
9.9.4 Sysmex Corporation Sepsis Detection Kit Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.9.5 Sysmex Corporation Recent Developments/Updates
9.9.6 Sysmex Corporation Competitive Strengths & Weaknesses
9.10 Bruker Corporation
9.10.1 Bruker Corporation Details
9.10.2 Bruker Corporation Major Business
9.10.3 Bruker Corporation Sepsis Detection Kit Product and Services
9.10.4 Bruker Corporation Sepsis Detection Kit Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.10.5 Bruker Corporation Recent Developments/Updates
9.10.6 Bruker Corporation Competitive Strengths & Weaknesses
9.11 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
9.11.1 Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Details
9.11.2 Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Major Business
9.11.3 Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Sepsis Detection Kit Product and Services
9.11.4 Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Sepsis Detection Kit Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.11.5 Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Recent Developments/Updates
9.11.6 Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Competitive Strengths & Weaknesses
9.12 T2 Biosystems, Inc.
9.12.1 T2 Biosystems, Inc. Details
9.12.2 T2 Biosystems, Inc. Major Business
9.12.3 T2 Biosystems, Inc. Sepsis Detection Kit Product and Services
9.12.4 T2 Biosystems, Inc. Sepsis Detection Kit Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.12.5 T2 Biosystems, Inc. Recent Developments/Updates
9.12.6 T2 Biosystems, Inc. Competitive Strengths & Weaknesses
9.13 Guangzhou Wondfo Biotech Co., Ltd.
9.13.1 Guangzhou Wondfo Biotech Co., Ltd. Details
9.13.2 Guangzhou Wondfo Biotech Co., Ltd. Major Business
9.13.3 Guangzhou Wondfo Biotech Co., Ltd. Sepsis Detection Kit Product and Services
9.13.4 Guangzhou Wondfo Biotech Co., Ltd. Sepsis Detection Kit Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.13.5 Guangzhou Wondfo Biotech Co., Ltd. Recent Developments/Updates
9.13.6 Guangzhou Wondfo Biotech Co., Ltd. Competitive Strengths & Weaknesses
9.14 Getein Biotech, Inc.
9.14.1 Getein Biotech, Inc. Details
9.14.2 Getein Biotech, Inc. Major Business
9.14.3 Getein Biotech, Inc. Sepsis Detection Kit Product and Services
9.14.4 Getein Biotech, Inc. Sepsis Detection Kit Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.14.5 Getein Biotech, Inc. Recent Developments/Updates
9.14.6 Getein Biotech, Inc. Competitive Strengths & Weaknesses
9.15 Boditech Med Inc.
9.15.1 Boditech Med Inc. Details
9.15.2 Boditech Med Inc. Major Business
9.15.3 Boditech Med Inc. Sepsis Detection Kit Product and Services
9.15.4 Boditech Med Inc. Sepsis Detection Kit Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.15.5 Boditech Med Inc. Recent Developments/Updates
9.15.6 Boditech Med Inc. Competitive Strengths & Weaknesses
9.16 SD Biosensor, Inc.
9.16.1 SD Biosensor, Inc. Details
9.16.2 SD Biosensor, Inc. Major Business
9.16.3 SD Biosensor, Inc. Sepsis Detection Kit Product and Services
9.16.4 SD Biosensor, Inc. Sepsis Detection Kit Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.16.5 SD Biosensor, Inc. Recent Developments/Updates
9.16.6 SD Biosensor, Inc. Competitive Strengths & Weaknesses
9.17 Cytovale, Inc.
9.17.1 Cytovale, Inc. Details
9.17.2 Cytovale, Inc. Major Business
9.17.3 Cytovale, Inc. Sepsis Detection Kit Product and Services
9.17.4 Cytovale, Inc. Sepsis Detection Kit Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.17.5 Cytovale, Inc. Recent Developments/Updates
9.17.6 Cytovale, Inc. Competitive Strengths & Weaknesses
9.18 Immunexpress Pty Ltd
9.18.1 Immunexpress Pty Ltd Details
9.18.2 Immunexpress Pty Ltd Major Business
9.18.3 Immunexpress Pty Ltd Sepsis Detection Kit Product and Services
9.18.4 Immunexpress Pty Ltd Sepsis Detection Kit Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.18.5 Immunexpress Pty Ltd Recent Developments/Updates
9.18.6 Immunexpress Pty Ltd Competitive Strengths & Weaknesses
9.19 Inflammatix, Inc.
9.19.1 Inflammatix, Inc. Details
9.19.2 Inflammatix, Inc. Major Business
9.19.3 Inflammatix, Inc. Sepsis Detection Kit Product and Services
9.19.4 Inflammatix, Inc. Sepsis Detection Kit Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.19.5 Inflammatix, Inc. Recent Developments/Updates
9.19.6 Inflammatix, Inc. Competitive Strengths & Weaknesses
9.20 QIAGEN N.V.
9.20.1 QIAGEN N.V. Details
9.20.2 QIAGEN N.V. Major Business
9.20.3 QIAGEN N.V. Sepsis Detection Kit Product and Services
9.20.4 QIAGEN N.V. Sepsis Detection Kit Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.20.5 QIAGEN N.V. Recent Developments/Updates
9.20.6 QIAGEN N.V. Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Sepsis Detection Kit Industry Chain
10.2 Sepsis Detection Kit Upstream Analysis
10.2.1 Sepsis Detection Kit Core Raw Materials
10.2.2 Main Manufacturers of Sepsis Detection Kit Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 Sepsis Detection Kit Production Mode
10.6 Sepsis Detection Kit Procurement Model
10.7 Sepsis Detection Kit Industry Sales Model and Sales Channels
10.7.1 Sepsis Detection Kit Sales Model
10.7.2 Sepsis Detection Kit Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Sepsis Detection Kit Introduction
1.2 World Sepsis Detection Kit Supply & Forecast
1.2.1 World Sepsis Detection Kit Production Value (2021 & 2025 & 2032)
1.2.2 World Sepsis Detection Kit Production (2021-2032)
1.2.3 World Sepsis Detection Kit Pricing Trends (2021-2032)
1.3 World Sepsis Detection Kit Production by Region (Based on Production Site)
1.3.1 World Sepsis Detection Kit Production Value by Region (2021-2032)
1.3.2 World Sepsis Detection Kit Production by Region (2021-2032)
1.3.3 World Sepsis Detection Kit Average Price by Region (2021-2032)
1.3.4 North America Sepsis Detection Kit Production (2021-2032)
1.3.5 Europe Sepsis Detection Kit Production (2021-2032)
1.3.6 China Sepsis Detection Kit Production (2021-2032)
1.3.7 Japan Sepsis Detection Kit Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Sepsis Detection Kit Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Sepsis Detection Kit Major Market Trends
2 DEMAND SUMMARY
2.1 World Sepsis Detection Kit Demand (2021-2032)
2.2 World Sepsis Detection Kit Consumption by Region
2.2.1 World Sepsis Detection Kit Consumption by Region (2021-2026)
2.2.2 World Sepsis Detection Kit Consumption Forecast by Region (2027-2032)
2.3 United States Sepsis Detection Kit Consumption (2021-2032)
2.4 China Sepsis Detection Kit Consumption (2021-2032)
2.5 Europe Sepsis Detection Kit Consumption (2021-2032)
2.6 Japan Sepsis Detection Kit Consumption (2021-2032)
2.7 South Korea Sepsis Detection Kit Consumption (2021-2032)
2.8 ASEAN Sepsis Detection Kit Consumption (2021-2032)
2.9 India Sepsis Detection Kit Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Sepsis Detection Kit Production Value by Manufacturer (2021-2026)
3.2 World Sepsis Detection Kit Production by Manufacturer (2021-2026)
3.3 World Sepsis Detection Kit Average Price by Manufacturer (2021-2026)
3.4 Sepsis Detection Kit Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Sepsis Detection Kit Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Sepsis Detection Kit in 2025
3.5.3 Global Concentration Ratios (CR8) for Sepsis Detection Kit in 2025
3.6 Sepsis Detection Kit Market: Overall Company Footprint Analysis
3.6.1 Sepsis Detection Kit Market: Region Footprint
3.6.2 Sepsis Detection Kit Market: Company Product Type Footprint
3.6.3 Sepsis Detection Kit Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Sepsis Detection Kit Production Value Comparison
4.1.1 United States VS China: Sepsis Detection Kit Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Sepsis Detection Kit Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Sepsis Detection Kit Production Comparison
4.2.1 United States VS China: Sepsis Detection Kit Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Sepsis Detection Kit Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Sepsis Detection Kit Consumption Comparison
4.3.1 United States VS China: Sepsis Detection Kit Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Sepsis Detection Kit Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Sepsis Detection Kit Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Sepsis Detection Kit Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Sepsis Detection Kit Production Value (2021-2026)
4.4.3 United States Based Manufacturers Sepsis Detection Kit Production (2021-2026)
4.5 China Based Sepsis Detection Kit Manufacturers and Market Share
4.5.1 China Based Sepsis Detection Kit Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Sepsis Detection Kit Production Value (2021-2026)
4.5.3 China Based Manufacturers Sepsis Detection Kit Production (2021-2026)
4.6 Rest of World Based Sepsis Detection Kit Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Sepsis Detection Kit Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Sepsis Detection Kit Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Sepsis Detection Kit Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Sepsis Detection Kit Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Immunochromatography
5.2.2 Molecular Biology
5.3 Market Segment by Type
5.3.1 World Sepsis Detection Kit Production by Type (2021-2032)
5.3.2 World Sepsis Detection Kit Production Value by Type (2021-2032)
5.3.3 World Sepsis Detection Kit Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY DETECTION TARGET
6.1 World Sepsis Detection Kit Market Size Overview by Detection Target: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Detection Target
6.2.1 Single Biomarker
6.2.2 Multi-indicator Combined Detection
6.3 Market Segment by Detection Target
6.3.1 World Sepsis Detection Kit Production by Detection Target (2021-2032)
6.3.2 World Sepsis Detection Kit Production Value by Detection Target (2021-2032)
6.3.3 World Sepsis Detection Kit Average Price by Detection Target (2021-2032)
7 MARKET ANALYSIS BY DETECTION TIME
7.1 World Sepsis Detection Kit Market Size Overview by Detection Time: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Detection Time
7.2.1 ≤30 minutes
7.2.2 0.5~4 hours
7.2.3 ≥4 hours
7.3 Market Segment by Detection Time
7.3.1 World Sepsis Detection Kit Production by Detection Time (2021-2032)
7.3.2 World Sepsis Detection Kit Production Value by Detection Time (2021-2032)
7.3.3 World Sepsis Detection Kit Average Price by Detection Time (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Sepsis Detection Kit Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 General Hospitals
8.2.2 Medical Laboratory (ICL) Industry
8.2.3 Maternal and Child Health Industry
8.2.4 Others
8.3 Market Segment by Application
8.3.1 World Sepsis Detection Kit Production by Application (2021-2032)
8.3.2 World Sepsis Detection Kit Production Value by Application (2021-2032)
8.3.3 World Sepsis Detection Kit Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 BioM?rieux SA
9.1.1 BioM?rieux SA Details
9.1.2 BioM?rieux SA Major Business
9.1.3 BioM?rieux SA Sepsis Detection Kit Product and Services
9.1.4 BioM?rieux SA Sepsis Detection Kit Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 BioM?rieux SA Recent Developments/Updates
9.1.6 BioM?rieux SA Competitive Strengths & Weaknesses
9.2 Roche Holding Ltd
9.2.1 Roche Holding Ltd Details
9.2.2 Roche Holding Ltd Major Business
9.2.3 Roche Holding Ltd Sepsis Detection Kit Product and Services
9.2.4 Roche Holding Ltd Sepsis Detection Kit Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 Roche Holding Ltd Recent Developments/Updates
9.2.6 Roche Holding Ltd Competitive Strengths & Weaknesses
9.3 Thermo Fisher Scientific Inc.
9.3.1 Thermo Fisher Scientific Inc. Details
9.3.2 Thermo Fisher Scientific Inc. Major Business
9.3.3 Thermo Fisher Scientific Inc. Sepsis Detection Kit Product and Services
9.3.4 Thermo Fisher Scientific Inc. Sepsis Detection Kit Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 Thermo Fisher Scientific Inc. Recent Developments/Updates
9.3.6 Thermo Fisher Scientific Inc. Competitive Strengths & Weaknesses
9.4 Abbott Laboratories
9.4.1 Abbott Laboratories Details
9.4.2 Abbott Laboratories Major Business
9.4.3 Abbott Laboratories Sepsis Detection Kit Product and Services
9.4.4 Abbott Laboratories Sepsis Detection Kit Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 Abbott Laboratories Recent Developments/Updates
9.4.6 Abbott Laboratories Competitive Strengths & Weaknesses
9.5 Siemens Healthineers AG
9.5.1 Siemens Healthineers AG Details
9.5.2 Siemens Healthineers AG Major Business
9.5.3 Siemens Healthineers AG Sepsis Detection Kit Product and Services
9.5.4 Siemens Healthineers AG Sepsis Detection Kit Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.5.5 Siemens Healthineers AG Recent Developments/Updates
9.5.6 Siemens Healthineers AG Competitive Strengths & Weaknesses
9.6 DiaSorin S.p.A.
9.6.1 DiaSorin S.p.A. Details
9.6.2 DiaSorin S.p.A. Major Business
9.6.3 DiaSorin S.p.A. Sepsis Detection Kit Product and Services
9.6.4 DiaSorin S.p.A. Sepsis Detection Kit Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.6.5 DiaSorin S.p.A. Recent Developments/Updates
9.6.6 DiaSorin S.p.A. Competitive Strengths & Weaknesses
9.7 QuidelOrtho Corporation
9.7.1 QuidelOrtho Corporation Details
9.7.2 QuidelOrtho Corporation Major Business
9.7.3 QuidelOrtho Corporation Sepsis Detection Kit Product and Services
9.7.4 QuidelOrtho Corporation Sepsis Detection Kit Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.7.5 QuidelOrtho Corporation Recent Developments/Updates
9.7.6 QuidelOrtho Corporation Competitive Strengths & Weaknesses
9.8 PHC Holdings Corporation
9.8.1 PHC Holdings Corporation Details
9.8.2 PHC Holdings Corporation Major Business
9.8.3 PHC Holdings Corporation Sepsis Detection Kit Product and Services
9.8.4 PHC Holdings Corporation Sepsis Detection Kit Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.8.5 PHC Holdings Corporation Recent Developments/Updates
9.8.6 PHC Holdings Corporation Competitive Strengths & Weaknesses
9.9 Sysmex Corporation
9.9.1 Sysmex Corporation Details
9.9.2 Sysmex Corporation Major Business
9.9.3 Sysmex Corporation Sepsis Detection Kit Product and Services
9.9.4 Sysmex Corporation Sepsis Detection Kit Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.9.5 Sysmex Corporation Recent Developments/Updates
9.9.6 Sysmex Corporation Competitive Strengths & Weaknesses
9.10 Bruker Corporation
9.10.1 Bruker Corporation Details
9.10.2 Bruker Corporation Major Business
9.10.3 Bruker Corporation Sepsis Detection Kit Product and Services
9.10.4 Bruker Corporation Sepsis Detection Kit Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.10.5 Bruker Corporation Recent Developments/Updates
9.10.6 Bruker Corporation Competitive Strengths & Weaknesses
9.11 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
9.11.1 Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Details
9.11.2 Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Major Business
9.11.3 Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Sepsis Detection Kit Product and Services
9.11.4 Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Sepsis Detection Kit Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.11.5 Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Recent Developments/Updates
9.11.6 Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Competitive Strengths & Weaknesses
9.12 T2 Biosystems, Inc.
9.12.1 T2 Biosystems, Inc. Details
9.12.2 T2 Biosystems, Inc. Major Business
9.12.3 T2 Biosystems, Inc. Sepsis Detection Kit Product and Services
9.12.4 T2 Biosystems, Inc. Sepsis Detection Kit Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.12.5 T2 Biosystems, Inc. Recent Developments/Updates
9.12.6 T2 Biosystems, Inc. Competitive Strengths & Weaknesses
9.13 Guangzhou Wondfo Biotech Co., Ltd.
9.13.1 Guangzhou Wondfo Biotech Co., Ltd. Details
9.13.2 Guangzhou Wondfo Biotech Co., Ltd. Major Business
9.13.3 Guangzhou Wondfo Biotech Co., Ltd. Sepsis Detection Kit Product and Services
9.13.4 Guangzhou Wondfo Biotech Co., Ltd. Sepsis Detection Kit Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.13.5 Guangzhou Wondfo Biotech Co., Ltd. Recent Developments/Updates
9.13.6 Guangzhou Wondfo Biotech Co., Ltd. Competitive Strengths & Weaknesses
9.14 Getein Biotech, Inc.
9.14.1 Getein Biotech, Inc. Details
9.14.2 Getein Biotech, Inc. Major Business
9.14.3 Getein Biotech, Inc. Sepsis Detection Kit Product and Services
9.14.4 Getein Biotech, Inc. Sepsis Detection Kit Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.14.5 Getein Biotech, Inc. Recent Developments/Updates
9.14.6 Getein Biotech, Inc. Competitive Strengths & Weaknesses
9.15 Boditech Med Inc.
9.15.1 Boditech Med Inc. Details
9.15.2 Boditech Med Inc. Major Business
9.15.3 Boditech Med Inc. Sepsis Detection Kit Product and Services
9.15.4 Boditech Med Inc. Sepsis Detection Kit Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.15.5 Boditech Med Inc. Recent Developments/Updates
9.15.6 Boditech Med Inc. Competitive Strengths & Weaknesses
9.16 SD Biosensor, Inc.
9.16.1 SD Biosensor, Inc. Details
9.16.2 SD Biosensor, Inc. Major Business
9.16.3 SD Biosensor, Inc. Sepsis Detection Kit Product and Services
9.16.4 SD Biosensor, Inc. Sepsis Detection Kit Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.16.5 SD Biosensor, Inc. Recent Developments/Updates
9.16.6 SD Biosensor, Inc. Competitive Strengths & Weaknesses
9.17 Cytovale, Inc.
9.17.1 Cytovale, Inc. Details
9.17.2 Cytovale, Inc. Major Business
9.17.3 Cytovale, Inc. Sepsis Detection Kit Product and Services
9.17.4 Cytovale, Inc. Sepsis Detection Kit Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.17.5 Cytovale, Inc. Recent Developments/Updates
9.17.6 Cytovale, Inc. Competitive Strengths & Weaknesses
9.18 Immunexpress Pty Ltd
9.18.1 Immunexpress Pty Ltd Details
9.18.2 Immunexpress Pty Ltd Major Business
9.18.3 Immunexpress Pty Ltd Sepsis Detection Kit Product and Services
9.18.4 Immunexpress Pty Ltd Sepsis Detection Kit Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.18.5 Immunexpress Pty Ltd Recent Developments/Updates
9.18.6 Immunexpress Pty Ltd Competitive Strengths & Weaknesses
9.19 Inflammatix, Inc.
9.19.1 Inflammatix, Inc. Details
9.19.2 Inflammatix, Inc. Major Business
9.19.3 Inflammatix, Inc. Sepsis Detection Kit Product and Services
9.19.4 Inflammatix, Inc. Sepsis Detection Kit Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.19.5 Inflammatix, Inc. Recent Developments/Updates
9.19.6 Inflammatix, Inc. Competitive Strengths & Weaknesses
9.20 QIAGEN N.V.
9.20.1 QIAGEN N.V. Details
9.20.2 QIAGEN N.V. Major Business
9.20.3 QIAGEN N.V. Sepsis Detection Kit Product and Services
9.20.4 QIAGEN N.V. Sepsis Detection Kit Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.20.5 QIAGEN N.V. Recent Developments/Updates
9.20.6 QIAGEN N.V. Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Sepsis Detection Kit Industry Chain
10.2 Sepsis Detection Kit Upstream Analysis
10.2.1 Sepsis Detection Kit Core Raw Materials
10.2.2 Main Manufacturers of Sepsis Detection Kit Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 Sepsis Detection Kit Production Mode
10.6 Sepsis Detection Kit Procurement Model
10.7 Sepsis Detection Kit Industry Sales Model and Sales Channels
10.7.1 Sepsis Detection Kit Sales Model
10.7.2 Sepsis Detection Kit Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Sepsis Detection Kit Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Sepsis Detection Kit Production Value by Region (2021-2026) & (USD Million)
Table 3. World Sepsis Detection Kit Production Value by Region (2027-2032) & (USD Million)
Table 4. World Sepsis Detection Kit Production Value Market Share by Region (2021-2026)
Table 5. World Sepsis Detection Kit Production Value Market Share by Region (2027-2032)
Table 6. World Sepsis Detection Kit Production by Region (2021-2026) & (K Units)
Table 7. World Sepsis Detection Kit Production by Region (2027-2032) & (K Units)
Table 8. World Sepsis Detection Kit Production Market Share by Region (2021-2026)
Table 9. World Sepsis Detection Kit Production Market Share by Region (2027-2032)
Table 10. World Sepsis Detection Kit Average Price by Region (2021-2026) & (US$/Unit)
Table 11. World Sepsis Detection Kit Average Price by Region (2027-2032) & (US$/Unit)
Table 12. Sepsis Detection Kit Major Market Trends
Table 13. World Sepsis Detection Kit Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Units)
Table 14. World Sepsis Detection Kit Consumption by Region (2021-2026) & (K Units)
Table 15. World Sepsis Detection Kit Consumption Forecast by Region (2027-2032) & (K Units)
Table 16. World Sepsis Detection Kit Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Sepsis Detection Kit Producers in 2025
Table 18. World Sepsis Detection Kit Production by Manufacturer (2021-2026) & (K Units)
Table 19. Production Market Share of Key Sepsis Detection Kit Producers in 2025
Table 20. World Sepsis Detection Kit Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 21. Global Sepsis Detection Kit Company Evaluation Quadrant
Table 22. World Sepsis Detection Kit Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Sepsis Detection Kit Production Site of Key Manufacturer
Table 24. Sepsis Detection Kit Market: Company Product Type Footprint
Table 25. Sepsis Detection Kit Market: Company Product Application Footprint
Table 26. Sepsis Detection Kit Competitive Factors
Table 27. Sepsis Detection Kit New Entrant and Capacity Expansion Plans
Table 28. Sepsis Detection Kit Mergers & Acquisitions Activity
Table 29. United States VS China Sepsis Detection Kit Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Sepsis Detection Kit Production Comparison, (2021 & 2025 & 2032) & (K Units)
Table 31. United States VS China Sepsis Detection Kit Consumption Comparison, (2021 & 2025 & 2032) & (K Units)
Table 32. United States Based Sepsis Detection Kit Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Sepsis Detection Kit Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Sepsis Detection Kit Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Sepsis Detection Kit Production (2021-2026) & (K Units)
Table 36. United States Based Manufacturers Sepsis Detection Kit Production Market Share (2021-2026)
Table 37. China Based Sepsis Detection Kit Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Sepsis Detection Kit Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Sepsis Detection Kit Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Sepsis Detection Kit Production, (2021-2026) & (K Units)
Table 41. China Based Manufacturers Sepsis Detection Kit Production Market Share (2021-2026)
Table 42. Rest of World Based Sepsis Detection Kit Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Sepsis Detection Kit Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Sepsis Detection Kit Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Sepsis Detection Kit Production, (2021-2026) & (K Units)
Table 46. Rest of World Based Manufacturers Sepsis Detection Kit Production Market Share (2021-2026)
Table 47. World Sepsis Detection Kit Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Sepsis Detection Kit Production by Type (2021-2026) & (K Units)
Table 49. World Sepsis Detection Kit Production by Type (2027-2032) & (K Units)
Table 50. World Sepsis Detection Kit Production Value by Type (2021-2026) & (USD Million)
Table 51. World Sepsis Detection Kit Production Value by Type (2027-2032) & (USD Million)
Table 52. World Sepsis Detection Kit Average Price by Type (2021-2026) & (US$/Unit)
Table 53. World Sepsis Detection Kit Average Price by Type (2027-2032) & (US$/Unit)
Table 54. World Sepsis Detection Kit Production Value by Detection Target, (USD Million), 2021 & 2025 & 2032
Table 55. World Sepsis Detection Kit Production by Detection Target (2021-2026) & (K Units)
Table 56. World Sepsis Detection Kit Production by Detection Target (2027-2032) & (K Units)
Table 57. World Sepsis Detection Kit Production Value by Detection Target (2021-2026) & (USD Million)
Table 58. World Sepsis Detection Kit Production Value by Detection Target (2027-2032) & (USD Million)
Table 59. World Sepsis Detection Kit Average Price by Detection Target (2021-2026) & (US$/Unit)
Table 60. World Sepsis Detection Kit Average Price by Detection Target (2027-2032) & (US$/Unit)
Table 61. World Sepsis Detection Kit Production Value by Detection Time, (USD Million), 2021 & 2025 & 2032
Table 62. World Sepsis Detection Kit Production by Detection Time (2021-2026) & (K Units)
Table 63. World Sepsis Detection Kit Production by Detection Time (2027-2032) & (K Units)
Table 64. World Sepsis Detection Kit Production Value by Detection Time (2021-2026) & (USD Million)
Table 65. World Sepsis Detection Kit Production Value by Detection Time (2027-2032) & (USD Million)
Table 66. World Sepsis Detection Kit Average Price by Detection Time (2021-2026) & (US$/Unit)
Table 67. World Sepsis Detection Kit Average Price by Detection Time (2027-2032) & (US$/Unit)
Table 68. World Sepsis Detection Kit Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World Sepsis Detection Kit Production by Application (2021-2026) & (K Units)
Table 70. World Sepsis Detection Kit Production by Application (2027-2032) & (K Units)
Table 71. World Sepsis Detection Kit Production Value by Application (2021-2026) & (USD Million)
Table 72. World Sepsis Detection Kit Production Value by Application (2027-2032) & (USD Million)
Table 73. World Sepsis Detection Kit Average Price by Application (2021-2026) & (US$/Unit)
Table 74. World Sepsis Detection Kit Average Price by Application (2027-2032) & (US$/Unit)
Table 75. BioM?rieux SA Basic Information, Manufacturing Base and Competitors
Table 76. BioM?rieux SA Major Business
Table 77. BioM?rieux SA Sepsis Detection Kit Product and Services
Table 78. BioM?rieux SA Sepsis Detection Kit Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. BioM?rieux SA Recent Developments/Updates
Table 80. BioM?rieux SA Competitive Strengths & Weaknesses
Table 81. Roche Holding Ltd Basic Information, Manufacturing Base and Competitors
Table 82. Roche Holding Ltd Major Business
Table 83. Roche Holding Ltd Sepsis Detection Kit Product and Services
Table 84. Roche Holding Ltd Sepsis Detection Kit Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Roche Holding Ltd Recent Developments/Updates
Table 86. Roche Holding Ltd Competitive Strengths & Weaknesses
Table 87. Thermo Fisher Scientific Inc. Basic Information, Manufacturing Base and Competitors
Table 88. Thermo Fisher Scientific Inc. Major Business
Table 89. Thermo Fisher Scientific Inc. Sepsis Detection Kit Product and Services
Table 90. Thermo Fisher Scientific Inc. Sepsis Detection Kit Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. Thermo Fisher Scientific Inc. Recent Developments/Updates
Table 92. Thermo Fisher Scientific Inc. Competitive Strengths & Weaknesses
Table 93. Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table 94. Abbott Laboratories Major Business
Table 95. Abbott Laboratories Sepsis Detection Kit Product and Services
Table 96. Abbott Laboratories Sepsis Detection Kit Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. Abbott Laboratories Recent Developments/Updates
Table 98. Abbott Laboratories Competitive Strengths & Weaknesses
Table 99. Siemens Healthineers AG Basic Information, Manufacturing Base and Competitors
Table 100. Siemens Healthineers AG Major Business
Table 101. Siemens Healthineers AG Sepsis Detection Kit Product and Services
Table 102. Siemens Healthineers AG Sepsis Detection Kit Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. Siemens Healthineers AG Recent Developments/Updates
Table 104. Siemens Healthineers AG Competitive Strengths & Weaknesses
Table 105. DiaSorin S.p.A. Basic Information, Manufacturing Base and Competitors
Table 106. DiaSorin S.p.A. Major Business
Table 107. DiaSorin S.p.A. Sepsis Detection Kit Product and Services
Table 108. DiaSorin S.p.A. Sepsis Detection Kit Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. DiaSorin S.p.A. Recent Developments/Updates
Table 110. DiaSorin S.p.A. Competitive Strengths & Weaknesses
Table 111. QuidelOrtho Corporation Basic Information, Manufacturing Base and Competitors
Table 112. QuidelOrtho Corporation Major Business
Table 113. QuidelOrtho Corporation Sepsis Detection Kit Product and Services
Table 114. QuidelOrtho Corporation Sepsis Detection Kit Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. QuidelOrtho Corporation Recent Developments/Updates
Table 116. QuidelOrtho Corporation Competitive Strengths & Weaknesses
Table 117. PHC Holdings Corporation Basic Information, Manufacturing Base and Competitors
Table 118. PHC Holdings Corporation Major Business
Table 119. PHC Holdings Corporation Sepsis Detection Kit Product and Services
Table 120. PHC Holdings Corporation Sepsis Detection Kit Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 121. PHC Holdings Corporation Recent Developments/Updates
Table 122. PHC Holdings Corporation Competitive Strengths & Weaknesses
Table 123. Sysmex Corporation Basic Information, Manufacturing Base and Competitors
Table 124. Sysmex Corporation Major Business
Table 125. Sysmex Corporation Sepsis Detection Kit Product and Services
Table 126. Sysmex Corporation Sepsis Detection Kit Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 127. Sysmex Corporation Recent Developments/Updates
Table 128. Sysmex Corporation Competitive Strengths & Weaknesses
Table 129. Bruker Corporation Basic Information, Manufacturing Base and Competitors
Table 130. Bruker Corporation Major Business
Table 131. Bruker Corporation Sepsis Detection Kit Product and Services
Table 132. Bruker Corporation Sepsis Detection Kit Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 133. Bruker Corporation Recent Developments/Updates
Table 134. Bruker Corporation Competitive Strengths & Weaknesses
Table 135. Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 136. Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Major Business
Table 137. Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Sepsis Detection Kit Product and Services
Table 138. Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Sepsis Detection Kit Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 139. Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Recent Developments/Updates
Table 140. Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Competitive Strengths & Weaknesses
Table 141. T2 Biosystems, Inc. Basic Information, Manufacturing Base and Competitors
Table 142. T2 Biosystems, Inc. Major Business
Table 143. T2 Biosystems, Inc. Sepsis Detection Kit Product and Services
Table 144. T2 Biosystems, Inc. Sepsis Detection Kit Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 145. T2 Biosystems, Inc. Recent Developments/Updates
Table 146. T2 Biosystems, Inc. Competitive Strengths & Weaknesses
Table 147. Guangzhou Wondfo Biotech Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 148. Guangzhou Wondfo Biotech Co., Ltd. Major Business
Table 149. Guangzhou Wondfo Biotech Co., Ltd. Sepsis Detection Kit Product and Services
Table 150. Guangzhou Wondfo Biotech Co., Ltd. Sepsis Detection Kit Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 151. Guangzhou Wondfo Biotech Co., Ltd. Recent Developments/Updates
Table 152. Guangzhou Wondfo Biotech Co., Ltd. Competitive Strengths & Weaknesses
Table 153. Getein Biotech, Inc. Basic Information, Manufacturing Base and Competitors
Table 154. Getein Biotech, Inc. Major Business
Table 155. Getein Biotech, Inc. Sepsis Detection Kit Product and Services
Table 156. Getein Biotech, Inc. Sepsis Detection Kit Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 157. Getein Biotech, Inc. Recent Developments/Updates
Table 158. Getein Biotech, Inc. Competitive Strengths & Weaknesses
Table 159. Boditech Med Inc. Basic Information, Manufacturing Base and Competitors
Table 160. Boditech Med Inc. Major Business
Table 161. Boditech Med Inc. Sepsis Detection Kit Product and Services
Table 162. Boditech Med Inc. Sepsis Detection Kit Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 163. Boditech Med Inc. Recent Developments/Updates
Table 164. Boditech Med Inc. Competitive Strengths & Weaknesses
Table 165. SD Biosensor, Inc. Basic Information, Manufacturing Base and Competitors
Table 166. SD Biosensor, Inc. Major Business
Table 167. SD Biosensor, Inc. Sepsis Detection Kit Product and Services
Table 168. SD Biosensor, Inc. Sepsis Detection Kit Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 169. SD Biosensor, Inc. Recent Developments/Updates
Table 170. SD Biosensor, Inc. Competitive Strengths & Weaknesses
Table 171. Cytovale, Inc. Basic Information, Manufacturing Base and Competitors
Table 172. Cytovale, Inc. Major Business
Table 173. Cytovale, Inc. Sepsis Detection Kit Product and Services
Table 174. Cytovale, Inc. Sepsis Detection Kit Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 175. Cytovale, Inc. Recent Developments/Updates
Table 176. Cytovale, Inc. Competitive Strengths & Weaknesses
Table 177. Immunexpress Pty Ltd Basic Information, Manufacturing Base and Competitors
Table 178. Immunexpress Pty Ltd Major Business
Table 179. Immunexpress Pty Ltd Sepsis Detection Kit Product and Services
Table 180. Immunexpress Pty Ltd Sepsis Detection Kit Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 181. Immunexpress Pty Ltd Recent Developments/Updates
Table 182. Immunexpress Pty Ltd Competitive Strengths & Weaknesses
Table 183. Inflammatix, Inc. Basic Information, Manufacturing Base and Competitors
Table 184. Inflammatix, Inc. Major Business
Table 185. Inflammatix, Inc. Sepsis Detection Kit Product and Services
Table 186. Inflammatix, Inc. Sepsis Detection Kit Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 187. Inflammatix, Inc. Recent Developments/Updates
Table 188. Inflammatix, Inc. Competitive Strengths & Weaknesses
Table 189. QIAGEN N.V. Basic Information, Manufacturing Base and Competitors
Table 190. QIAGEN N.V. Major Business
Table 191. QIAGEN N.V. Sepsis Detection Kit Product and Services
Table 192. QIAGEN N.V. Sepsis Detection Kit Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 193. QIAGEN N.V. Recent Developments/Updates
Table 194. QIAGEN N.V. Competitive Strengths & Weaknesses
Table 195. Global Key Players of Sepsis Detection Kit Upstream (Raw Materials)
Table 196. Global Sepsis Detection Kit Typical Customers
Table 197. Sepsis Detection Kit Typical Distributors
Table 1. World Sepsis Detection Kit Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Sepsis Detection Kit Production Value by Region (2021-2026) & (USD Million)
Table 3. World Sepsis Detection Kit Production Value by Region (2027-2032) & (USD Million)
Table 4. World Sepsis Detection Kit Production Value Market Share by Region (2021-2026)
Table 5. World Sepsis Detection Kit Production Value Market Share by Region (2027-2032)
Table 6. World Sepsis Detection Kit Production by Region (2021-2026) & (K Units)
Table 7. World Sepsis Detection Kit Production by Region (2027-2032) & (K Units)
Table 8. World Sepsis Detection Kit Production Market Share by Region (2021-2026)
Table 9. World Sepsis Detection Kit Production Market Share by Region (2027-2032)
Table 10. World Sepsis Detection Kit Average Price by Region (2021-2026) & (US$/Unit)
Table 11. World Sepsis Detection Kit Average Price by Region (2027-2032) & (US$/Unit)
Table 12. Sepsis Detection Kit Major Market Trends
Table 13. World Sepsis Detection Kit Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Units)
Table 14. World Sepsis Detection Kit Consumption by Region (2021-2026) & (K Units)
Table 15. World Sepsis Detection Kit Consumption Forecast by Region (2027-2032) & (K Units)
Table 16. World Sepsis Detection Kit Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Sepsis Detection Kit Producers in 2025
Table 18. World Sepsis Detection Kit Production by Manufacturer (2021-2026) & (K Units)
Table 19. Production Market Share of Key Sepsis Detection Kit Producers in 2025
Table 20. World Sepsis Detection Kit Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 21. Global Sepsis Detection Kit Company Evaluation Quadrant
Table 22. World Sepsis Detection Kit Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Sepsis Detection Kit Production Site of Key Manufacturer
Table 24. Sepsis Detection Kit Market: Company Product Type Footprint
Table 25. Sepsis Detection Kit Market: Company Product Application Footprint
Table 26. Sepsis Detection Kit Competitive Factors
Table 27. Sepsis Detection Kit New Entrant and Capacity Expansion Plans
Table 28. Sepsis Detection Kit Mergers & Acquisitions Activity
Table 29. United States VS China Sepsis Detection Kit Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Sepsis Detection Kit Production Comparison, (2021 & 2025 & 2032) & (K Units)
Table 31. United States VS China Sepsis Detection Kit Consumption Comparison, (2021 & 2025 & 2032) & (K Units)
Table 32. United States Based Sepsis Detection Kit Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Sepsis Detection Kit Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Sepsis Detection Kit Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Sepsis Detection Kit Production (2021-2026) & (K Units)
Table 36. United States Based Manufacturers Sepsis Detection Kit Production Market Share (2021-2026)
Table 37. China Based Sepsis Detection Kit Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Sepsis Detection Kit Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Sepsis Detection Kit Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Sepsis Detection Kit Production, (2021-2026) & (K Units)
Table 41. China Based Manufacturers Sepsis Detection Kit Production Market Share (2021-2026)
Table 42. Rest of World Based Sepsis Detection Kit Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Sepsis Detection Kit Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Sepsis Detection Kit Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Sepsis Detection Kit Production, (2021-2026) & (K Units)
Table 46. Rest of World Based Manufacturers Sepsis Detection Kit Production Market Share (2021-2026)
Table 47. World Sepsis Detection Kit Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Sepsis Detection Kit Production by Type (2021-2026) & (K Units)
Table 49. World Sepsis Detection Kit Production by Type (2027-2032) & (K Units)
Table 50. World Sepsis Detection Kit Production Value by Type (2021-2026) & (USD Million)
Table 51. World Sepsis Detection Kit Production Value by Type (2027-2032) & (USD Million)
Table 52. World Sepsis Detection Kit Average Price by Type (2021-2026) & (US$/Unit)
Table 53. World Sepsis Detection Kit Average Price by Type (2027-2032) & (US$/Unit)
Table 54. World Sepsis Detection Kit Production Value by Detection Target, (USD Million), 2021 & 2025 & 2032
Table 55. World Sepsis Detection Kit Production by Detection Target (2021-2026) & (K Units)
Table 56. World Sepsis Detection Kit Production by Detection Target (2027-2032) & (K Units)
Table 57. World Sepsis Detection Kit Production Value by Detection Target (2021-2026) & (USD Million)
Table 58. World Sepsis Detection Kit Production Value by Detection Target (2027-2032) & (USD Million)
Table 59. World Sepsis Detection Kit Average Price by Detection Target (2021-2026) & (US$/Unit)
Table 60. World Sepsis Detection Kit Average Price by Detection Target (2027-2032) & (US$/Unit)
Table 61. World Sepsis Detection Kit Production Value by Detection Time, (USD Million), 2021 & 2025 & 2032
Table 62. World Sepsis Detection Kit Production by Detection Time (2021-2026) & (K Units)
Table 63. World Sepsis Detection Kit Production by Detection Time (2027-2032) & (K Units)
Table 64. World Sepsis Detection Kit Production Value by Detection Time (2021-2026) & (USD Million)
Table 65. World Sepsis Detection Kit Production Value by Detection Time (2027-2032) & (USD Million)
Table 66. World Sepsis Detection Kit Average Price by Detection Time (2021-2026) & (US$/Unit)
Table 67. World Sepsis Detection Kit Average Price by Detection Time (2027-2032) & (US$/Unit)
Table 68. World Sepsis Detection Kit Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World Sepsis Detection Kit Production by Application (2021-2026) & (K Units)
Table 70. World Sepsis Detection Kit Production by Application (2027-2032) & (K Units)
Table 71. World Sepsis Detection Kit Production Value by Application (2021-2026) & (USD Million)
Table 72. World Sepsis Detection Kit Production Value by Application (2027-2032) & (USD Million)
Table 73. World Sepsis Detection Kit Average Price by Application (2021-2026) & (US$/Unit)
Table 74. World Sepsis Detection Kit Average Price by Application (2027-2032) & (US$/Unit)
Table 75. BioM?rieux SA Basic Information, Manufacturing Base and Competitors
Table 76. BioM?rieux SA Major Business
Table 77. BioM?rieux SA Sepsis Detection Kit Product and Services
Table 78. BioM?rieux SA Sepsis Detection Kit Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. BioM?rieux SA Recent Developments/Updates
Table 80. BioM?rieux SA Competitive Strengths & Weaknesses
Table 81. Roche Holding Ltd Basic Information, Manufacturing Base and Competitors
Table 82. Roche Holding Ltd Major Business
Table 83. Roche Holding Ltd Sepsis Detection Kit Product and Services
Table 84. Roche Holding Ltd Sepsis Detection Kit Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Roche Holding Ltd Recent Developments/Updates
Table 86. Roche Holding Ltd Competitive Strengths & Weaknesses
Table 87. Thermo Fisher Scientific Inc. Basic Information, Manufacturing Base and Competitors
Table 88. Thermo Fisher Scientific Inc. Major Business
Table 89. Thermo Fisher Scientific Inc. Sepsis Detection Kit Product and Services
Table 90. Thermo Fisher Scientific Inc. Sepsis Detection Kit Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. Thermo Fisher Scientific Inc. Recent Developments/Updates
Table 92. Thermo Fisher Scientific Inc. Competitive Strengths & Weaknesses
Table 93. Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table 94. Abbott Laboratories Major Business
Table 95. Abbott Laboratories Sepsis Detection Kit Product and Services
Table 96. Abbott Laboratories Sepsis Detection Kit Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. Abbott Laboratories Recent Developments/Updates
Table 98. Abbott Laboratories Competitive Strengths & Weaknesses
Table 99. Siemens Healthineers AG Basic Information, Manufacturing Base and Competitors
Table 100. Siemens Healthineers AG Major Business
Table 101. Siemens Healthineers AG Sepsis Detection Kit Product and Services
Table 102. Siemens Healthineers AG Sepsis Detection Kit Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. Siemens Healthineers AG Recent Developments/Updates
Table 104. Siemens Healthineers AG Competitive Strengths & Weaknesses
Table 105. DiaSorin S.p.A. Basic Information, Manufacturing Base and Competitors
Table 106. DiaSorin S.p.A. Major Business
Table 107. DiaSorin S.p.A. Sepsis Detection Kit Product and Services
Table 108. DiaSorin S.p.A. Sepsis Detection Kit Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. DiaSorin S.p.A. Recent Developments/Updates
Table 110. DiaSorin S.p.A. Competitive Strengths & Weaknesses
Table 111. QuidelOrtho Corporation Basic Information, Manufacturing Base and Competitors
Table 112. QuidelOrtho Corporation Major Business
Table 113. QuidelOrtho Corporation Sepsis Detection Kit Product and Services
Table 114. QuidelOrtho Corporation Sepsis Detection Kit Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. QuidelOrtho Corporation Recent Developments/Updates
Table 116. QuidelOrtho Corporation Competitive Strengths & Weaknesses
Table 117. PHC Holdings Corporation Basic Information, Manufacturing Base and Competitors
Table 118. PHC Holdings Corporation Major Business
Table 119. PHC Holdings Corporation Sepsis Detection Kit Product and Services
Table 120. PHC Holdings Corporation Sepsis Detection Kit Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 121. PHC Holdings Corporation Recent Developments/Updates
Table 122. PHC Holdings Corporation Competitive Strengths & Weaknesses
Table 123. Sysmex Corporation Basic Information, Manufacturing Base and Competitors
Table 124. Sysmex Corporation Major Business
Table 125. Sysmex Corporation Sepsis Detection Kit Product and Services
Table 126. Sysmex Corporation Sepsis Detection Kit Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 127. Sysmex Corporation Recent Developments/Updates
Table 128. Sysmex Corporation Competitive Strengths & Weaknesses
Table 129. Bruker Corporation Basic Information, Manufacturing Base and Competitors
Table 130. Bruker Corporation Major Business
Table 131. Bruker Corporation Sepsis Detection Kit Product and Services
Table 132. Bruker Corporation Sepsis Detection Kit Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 133. Bruker Corporation Recent Developments/Updates
Table 134. Bruker Corporation Competitive Strengths & Weaknesses
Table 135. Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 136. Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Major Business
Table 137. Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Sepsis Detection Kit Product and Services
Table 138. Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Sepsis Detection Kit Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 139. Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Recent Developments/Updates
Table 140. Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Competitive Strengths & Weaknesses
Table 141. T2 Biosystems, Inc. Basic Information, Manufacturing Base and Competitors
Table 142. T2 Biosystems, Inc. Major Business
Table 143. T2 Biosystems, Inc. Sepsis Detection Kit Product and Services
Table 144. T2 Biosystems, Inc. Sepsis Detection Kit Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 145. T2 Biosystems, Inc. Recent Developments/Updates
Table 146. T2 Biosystems, Inc. Competitive Strengths & Weaknesses
Table 147. Guangzhou Wondfo Biotech Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 148. Guangzhou Wondfo Biotech Co., Ltd. Major Business
Table 149. Guangzhou Wondfo Biotech Co., Ltd. Sepsis Detection Kit Product and Services
Table 150. Guangzhou Wondfo Biotech Co., Ltd. Sepsis Detection Kit Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 151. Guangzhou Wondfo Biotech Co., Ltd. Recent Developments/Updates
Table 152. Guangzhou Wondfo Biotech Co., Ltd. Competitive Strengths & Weaknesses
Table 153. Getein Biotech, Inc. Basic Information, Manufacturing Base and Competitors
Table 154. Getein Biotech, Inc. Major Business
Table 155. Getein Biotech, Inc. Sepsis Detection Kit Product and Services
Table 156. Getein Biotech, Inc. Sepsis Detection Kit Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 157. Getein Biotech, Inc. Recent Developments/Updates
Table 158. Getein Biotech, Inc. Competitive Strengths & Weaknesses
Table 159. Boditech Med Inc. Basic Information, Manufacturing Base and Competitors
Table 160. Boditech Med Inc. Major Business
Table 161. Boditech Med Inc. Sepsis Detection Kit Product and Services
Table 162. Boditech Med Inc. Sepsis Detection Kit Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 163. Boditech Med Inc. Recent Developments/Updates
Table 164. Boditech Med Inc. Competitive Strengths & Weaknesses
Table 165. SD Biosensor, Inc. Basic Information, Manufacturing Base and Competitors
Table 166. SD Biosensor, Inc. Major Business
Table 167. SD Biosensor, Inc. Sepsis Detection Kit Product and Services
Table 168. SD Biosensor, Inc. Sepsis Detection Kit Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 169. SD Biosensor, Inc. Recent Developments/Updates
Table 170. SD Biosensor, Inc. Competitive Strengths & Weaknesses
Table 171. Cytovale, Inc. Basic Information, Manufacturing Base and Competitors
Table 172. Cytovale, Inc. Major Business
Table 173. Cytovale, Inc. Sepsis Detection Kit Product and Services
Table 174. Cytovale, Inc. Sepsis Detection Kit Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 175. Cytovale, Inc. Recent Developments/Updates
Table 176. Cytovale, Inc. Competitive Strengths & Weaknesses
Table 177. Immunexpress Pty Ltd Basic Information, Manufacturing Base and Competitors
Table 178. Immunexpress Pty Ltd Major Business
Table 179. Immunexpress Pty Ltd Sepsis Detection Kit Product and Services
Table 180. Immunexpress Pty Ltd Sepsis Detection Kit Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 181. Immunexpress Pty Ltd Recent Developments/Updates
Table 182. Immunexpress Pty Ltd Competitive Strengths & Weaknesses
Table 183. Inflammatix, Inc. Basic Information, Manufacturing Base and Competitors
Table 184. Inflammatix, Inc. Major Business
Table 185. Inflammatix, Inc. Sepsis Detection Kit Product and Services
Table 186. Inflammatix, Inc. Sepsis Detection Kit Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 187. Inflammatix, Inc. Recent Developments/Updates
Table 188. Inflammatix, Inc. Competitive Strengths & Weaknesses
Table 189. QIAGEN N.V. Basic Information, Manufacturing Base and Competitors
Table 190. QIAGEN N.V. Major Business
Table 191. QIAGEN N.V. Sepsis Detection Kit Product and Services
Table 192. QIAGEN N.V. Sepsis Detection Kit Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 193. QIAGEN N.V. Recent Developments/Updates
Table 194. QIAGEN N.V. Competitive Strengths & Weaknesses
Table 195. Global Key Players of Sepsis Detection Kit Upstream (Raw Materials)
Table 196. Global Sepsis Detection Kit Typical Customers
Table 197. Sepsis Detection Kit Typical Distributors
LIST OF FIGURES
Figure 1. Sepsis Detection Kit Picture
Figure 2. World Sepsis Detection Kit Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Sepsis Detection Kit Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Sepsis Detection Kit Production (2021-2032) & (K Units)
Figure 5. World Sepsis Detection Kit Average Price (2021-2032) & (US$/Unit)
Figure 6. World Sepsis Detection Kit Production Value Market Share by Region (2021-2032)
Figure 7. World Sepsis Detection Kit Production Market Share by Region (2021-2032)
Figure 8. North America Sepsis Detection Kit Production (2021-2032) & (K Units)
Figure 9. Europe Sepsis Detection Kit Production (2021-2032) & (K Units)
Figure 10. China Sepsis Detection Kit Production (2021-2032) & (K Units)
Figure 11. Japan Sepsis Detection Kit Production (2021-2032) & (K Units)
Figure 12. Sepsis Detection Kit Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Sepsis Detection Kit Consumption (2021-2032) & (K Units)
Figure 15. World Sepsis Detection Kit Consumption Market Share by Region (2021-2032)
Figure 16. United States Sepsis Detection Kit Consumption (2021-2032) & (K Units)
Figure 17. China Sepsis Detection Kit Consumption (2021-2032) & (K Units)
Figure 18. Europe Sepsis Detection Kit Consumption (2021-2032) & (K Units)
Figure 19. Japan Sepsis Detection Kit Consumption (2021-2032) & (K Units)
Figure 20. South Korea Sepsis Detection Kit Consumption (2021-2032) & (K Units)
Figure 21. ASEAN Sepsis Detection Kit Consumption (2021-2032) & (K Units)
Figure 22. India Sepsis Detection Kit Consumption (2021-2032) & (K Units)
Figure 23. Producer Shipments of Sepsis Detection Kit by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 24. Global Four-firm Concentration Ratios (CR4) for Sepsis Detection Kit Markets in 2025
Figure 25. Global Four-firm Concentration Ratios (CR8) for Sepsis Detection Kit Markets in 2025
Figure 26. United States VS China: Sepsis Detection Kit Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: Sepsis Detection Kit Production Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Sepsis Detection Kit Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States Based Manufacturers Sepsis Detection Kit Production Market Share 2025
Figure 30. China Based Manufacturers Sepsis Detection Kit Production Market Share 2025
Figure 31. Rest of World Based Manufacturers Sepsis Detection Kit Production Market Share 2025
Figure 32. World Sepsis Detection Kit Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 33. World Sepsis Detection Kit Production Value Market Share by Type in 2025
Figure 34. Immunochromatography
Figure 35. Molecular Biology
Figure 36. World Sepsis Detection Kit Production Market Share by Type (2021-2032)
Figure 37. World Sepsis Detection Kit Production Value Market Share by Type (2021-2032)
Figure 38. World Sepsis Detection Kit Average Price by Type (2021-2032) & (US$/Unit)
Figure 39. World Sepsis Detection Kit Production Value by Detection Target, (USD Million), 2021 & 2025 & 2032
Figure 40. World Sepsis Detection Kit Production Value Market Share by Detection Target in 2025
Figure 41. Single Biomarker
Figure 42. Multi-indicator Combined Detection
Figure 43. World Sepsis Detection Kit Production Market Share by Detection Target (2021-2032)
Figure 44. World Sepsis Detection Kit Production Value Market Share by Detection Target (2021-2032)
Figure 45. World Sepsis Detection Kit Average Price by Detection Target (2021-2032) & (US$/Unit)
Figure 46. World Sepsis Detection Kit Production Value by Detection Time, (USD Million), 2021 & 2025 & 2032
Figure 47. World Sepsis Detection Kit Production Value Market Share by Detection Time in 2025
Figure 48. ≤30 minutes
Figure 49. 0.5~4 hours
Figure 50. ≥4 hours
Figure 51. World Sepsis Detection Kit Production Market Share by Detection Time (2021-2032)
Figure 52. World Sepsis Detection Kit Production Value Market Share by Detection Time (2021-2032)
Figure 53. World Sepsis Detection Kit Average Price by Detection Time (2021-2032) & (US$/Unit)
Figure 54. World Sepsis Detection Kit Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 55. World Sepsis Detection Kit Production Value Market Share by Application in 2025
Figure 56. General Hospitals
Figure 57. Medical Laboratory (ICL) Industry
Figure 58. Maternal and Child Health Industry
Figure 59. Others
Figure 60. World Sepsis Detection Kit Production Market Share by Application (2021-2032)
Figure 61. World Sepsis Detection Kit Production Value Market Share by Application (2021-2032)
Figure 62. World Sepsis Detection Kit Average Price by Application (2021-2032) & (US$/Unit)
Figure 63. Sepsis Detection Kit Industry Chain
Figure 64. Sepsis Detection Kit Procurement Model
Figure 65. Sepsis Detection Kit Sales Model
Figure 66. Sepsis Detection Kit Sales Channels, Direct Sales, and Distribution
Figure 67. Methodology
Figure 68. Research Process and Data Source
Figure 1. Sepsis Detection Kit Picture
Figure 2. World Sepsis Detection Kit Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Sepsis Detection Kit Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Sepsis Detection Kit Production (2021-2032) & (K Units)
Figure 5. World Sepsis Detection Kit Average Price (2021-2032) & (US$/Unit)
Figure 6. World Sepsis Detection Kit Production Value Market Share by Region (2021-2032)
Figure 7. World Sepsis Detection Kit Production Market Share by Region (2021-2032)
Figure 8. North America Sepsis Detection Kit Production (2021-2032) & (K Units)
Figure 9. Europe Sepsis Detection Kit Production (2021-2032) & (K Units)
Figure 10. China Sepsis Detection Kit Production (2021-2032) & (K Units)
Figure 11. Japan Sepsis Detection Kit Production (2021-2032) & (K Units)
Figure 12. Sepsis Detection Kit Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Sepsis Detection Kit Consumption (2021-2032) & (K Units)
Figure 15. World Sepsis Detection Kit Consumption Market Share by Region (2021-2032)
Figure 16. United States Sepsis Detection Kit Consumption (2021-2032) & (K Units)
Figure 17. China Sepsis Detection Kit Consumption (2021-2032) & (K Units)
Figure 18. Europe Sepsis Detection Kit Consumption (2021-2032) & (K Units)
Figure 19. Japan Sepsis Detection Kit Consumption (2021-2032) & (K Units)
Figure 20. South Korea Sepsis Detection Kit Consumption (2021-2032) & (K Units)
Figure 21. ASEAN Sepsis Detection Kit Consumption (2021-2032) & (K Units)
Figure 22. India Sepsis Detection Kit Consumption (2021-2032) & (K Units)
Figure 23. Producer Shipments of Sepsis Detection Kit by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 24. Global Four-firm Concentration Ratios (CR4) for Sepsis Detection Kit Markets in 2025
Figure 25. Global Four-firm Concentration Ratios (CR8) for Sepsis Detection Kit Markets in 2025
Figure 26. United States VS China: Sepsis Detection Kit Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: Sepsis Detection Kit Production Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Sepsis Detection Kit Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States Based Manufacturers Sepsis Detection Kit Production Market Share 2025
Figure 30. China Based Manufacturers Sepsis Detection Kit Production Market Share 2025
Figure 31. Rest of World Based Manufacturers Sepsis Detection Kit Production Market Share 2025
Figure 32. World Sepsis Detection Kit Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 33. World Sepsis Detection Kit Production Value Market Share by Type in 2025
Figure 34. Immunochromatography
Figure 35. Molecular Biology
Figure 36. World Sepsis Detection Kit Production Market Share by Type (2021-2032)
Figure 37. World Sepsis Detection Kit Production Value Market Share by Type (2021-2032)
Figure 38. World Sepsis Detection Kit Average Price by Type (2021-2032) & (US$/Unit)
Figure 39. World Sepsis Detection Kit Production Value by Detection Target, (USD Million), 2021 & 2025 & 2032
Figure 40. World Sepsis Detection Kit Production Value Market Share by Detection Target in 2025
Figure 41. Single Biomarker
Figure 42. Multi-indicator Combined Detection
Figure 43. World Sepsis Detection Kit Production Market Share by Detection Target (2021-2032)
Figure 44. World Sepsis Detection Kit Production Value Market Share by Detection Target (2021-2032)
Figure 45. World Sepsis Detection Kit Average Price by Detection Target (2021-2032) & (US$/Unit)
Figure 46. World Sepsis Detection Kit Production Value by Detection Time, (USD Million), 2021 & 2025 & 2032
Figure 47. World Sepsis Detection Kit Production Value Market Share by Detection Time in 2025
Figure 48. ≤30 minutes
Figure 49. 0.5~4 hours
Figure 50. ≥4 hours
Figure 51. World Sepsis Detection Kit Production Market Share by Detection Time (2021-2032)
Figure 52. World Sepsis Detection Kit Production Value Market Share by Detection Time (2021-2032)
Figure 53. World Sepsis Detection Kit Average Price by Detection Time (2021-2032) & (US$/Unit)
Figure 54. World Sepsis Detection Kit Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 55. World Sepsis Detection Kit Production Value Market Share by Application in 2025
Figure 56. General Hospitals
Figure 57. Medical Laboratory (ICL) Industry
Figure 58. Maternal and Child Health Industry
Figure 59. Others
Figure 60. World Sepsis Detection Kit Production Market Share by Application (2021-2032)
Figure 61. World Sepsis Detection Kit Production Value Market Share by Application (2021-2032)
Figure 62. World Sepsis Detection Kit Average Price by Application (2021-2032) & (US$/Unit)
Figure 63. Sepsis Detection Kit Industry Chain
Figure 64. Sepsis Detection Kit Procurement Model
Figure 65. Sepsis Detection Kit Sales Model
Figure 66. Sepsis Detection Kit Sales Channels, Direct Sales, and Distribution
Figure 67. Methodology
Figure 68. Research Process and Data Source
